159 related articles for article (PubMed ID: 7189630)
1. Diurnal change of serum androstenedione and testosterone and response to hCG and dexamethasone in women with polycystic ovaries, adrenal hyperandrogenism and unexplained hirsutism.
Lisse K; Schürenkämper P; Friedrich W; Rutkowsky J
Acta Endocrinol (Copenh); 1980 Feb; 93(2):216-22. PubMed ID: 7189630
[TBL] [Abstract][Full Text] [Related]
2. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic hirsutism--an ovarian abnormality.
Kirschner MA; Zucker IR; Jespersen D
N Engl J Med; 1976 Mar; 294(12):637-40. PubMed ID: 1246257
[TBL] [Abstract][Full Text] [Related]
4. The adrenal cortex and virilization.
McKenna TJ; Cunningham SK; Loughlin T
Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
[TBL] [Abstract][Full Text] [Related]
5. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
Givens JR; Andersen RN; Ragland JB; Wiser WL; Umstot ES
J Clin Endocrinol Metab; 1975 Jun; 40(6):988-1000. PubMed ID: 166091
[TBL] [Abstract][Full Text] [Related]
6. Ovarian and adrenal contributions to peripheral androgens in hirsute women.
Abraham GE; Chakmakjian ZH; Buster JE; Marshall JR
Obstet Gynecol; 1975 Aug; 46(2):169-73. PubMed ID: 125398
[TBL] [Abstract][Full Text] [Related]
7. Serum 11 beta-hydroxyandrostenedione as an indicator of the source of excess androgen production in women with polycystic ovaries.
Polson DW; Reed MJ; Franks S; Scanlon MJ; James VH
J Clin Endocrinol Metab; 1988 May; 66(5):946-50. PubMed ID: 3129451
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
Lobo RA; Goebelsmann U; Horton R
J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
[TBL] [Abstract][Full Text] [Related]
9. Suppression of testosterone and androstenedione porduction rates with dexamethasone in women with idiopathic hirsutsm and polycystic ovaries.
Bardin CW; Hembree WC; Lipsett MB
J Clin Endocrinol Metab; 1968 Sep; 28(9):1300-6. PubMed ID: 4300558
[No Abstract] [Full Text] [Related]
10. Diagnostic evaluation of hirsutism in women.
Farber M; Millan VG; Turksoy RN; Mitchell GW
Clin Obstet Gynecol; 1977 Mar; 20(1):1-9. PubMed ID: 837574
[TBL] [Abstract][Full Text] [Related]
11. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
Wajchenberg BL; Achando SS; Okada H; Czeresnia CE; Peixoto S; Lima SS; Goldman J
J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
[TBL] [Abstract][Full Text] [Related]
12. Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.
Thompson DL; Horton N; Rittmaster RS
Clin Endocrinol (Oxf); 1990 Mar; 32(3):283-92. PubMed ID: 2160872
[TBL] [Abstract][Full Text] [Related]
13. Correlation of the effects of dexamethasone administration on urinary 17-ketosteroid and serum androgen levels in patients with hirsutism.
Judd HL; McPherson RA; Rakoff JS; Yen SS
Am J Obstet Gynecol; 1977 Jun; 128(4):408-17. PubMed ID: 141210
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.
Fulghesu AM; Lanzone A; Apa R; Fortini A; Caruso A; Mancuso S
Gynecol Endocrinol; 1991 Mar; 5(1):37-48. PubMed ID: 1654730
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic evaluation of hirsutism in women by selective bilateral adrenal and ovarian venous catheterization.
Farber M; Millan VG; Turksoy RN; Mitchell GW
Fertil Steril; 1978 Sep; 30(3):283-8. PubMed ID: 710599
[TBL] [Abstract][Full Text] [Related]
16. Sex steroids, adiposity and smoking in the pathogenesis of idiopathic hirsutism and polycystic ovary syndrome.
Byrne B; Cunningham S; Igoe D; Conroy R; McKenna TJ
Acta Endocrinol (Copenh); 1991 Apr; 124(4):370-4. PubMed ID: 1827700
[TBL] [Abstract][Full Text] [Related]
17. Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism.
Pugeat M; Forest MG; Nisula BC; Corniau J; De Peretti E; Tourniaire J
Obstet Gynecol; 1982 Jan; 59(1):46-51. PubMed ID: 6804896
[TBL] [Abstract][Full Text] [Related]
18. Ovarian hyperthecosis in the adolescent patient.
Wentz AC; Gutai JP; Jones GS; Migeon CJ
J Pediatr; 1976 Mar; 88(3):488-93. PubMed ID: 1107505
[TBL] [Abstract][Full Text] [Related]
19. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
Frölich M; Lachinsky N; Moolenaar AJ
Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
[TBL] [Abstract][Full Text] [Related]
20. Long term effects of nightly dexamethasone administration in patients with polycystic ovarian disease.
Lachelin GC; Judd HL; Swanson SC; Hauck ME; Parker DC; Yen SS
J Clin Endocrinol Metab; 1982 Oct; 55(4):768-73. PubMed ID: 7107819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
